Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J5 · Effective Nov 12, 2023
8 active Medicare policies list A2023, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J5 · Effective Nov 12, 2023
J8 · Effective Nov 12, 2023
J9 · Effective Dec 1, 2024
JH · Effective Dec 1, 2024
JL · Effective Dec 1, 2024
J5 · Effective Oct 1, 2026
J9 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
6 policies from 6 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of A2023 |
|---|---|---|
| Skin and Soft Tissue Substitutes | Feb 9, 2024 | Covered |
| Policy | Effective | Status of A2023 |
|---|---|---|
| Skin and Soft Tissue Substitutes | Not recorded | Covered |
| Policy | Effective | Status of A2023 |
|---|---|---|
| Bioengineered Skin and Soft Tissue Substitutes | Jul 1, 2026 | Covered |
| Policy | Effective | Status of A2023 |
|---|---|---|
| Bioengineered Skin and Soft Tissue Substitutes | Jul 1, 2026 | Covered |
| Policy | Effective | Status of A2023 |
|---|---|---|
| Bioengineered Skin and Soft Tissue Substitutes | Jul 1, 2026 | Covered |
| Policy | Effective | Status of A2023 |
|---|---|---|
| Bioengineered Skin and Soft Tissue Substitutes | Jul 1, 2026 | Covered |